Hepatitis C Treatment Uptake by New Prescribers After the Introduction of Direct Acting Antivirals

J Gen Intern Med. 2020 Mar;35(3):975-977. doi: 10.1007/s11606-019-05200-6.

Authors

Shashi N Kapadia^{1

2}, Phyllis Johnson³, Bruce R Schackman³, Yuhua Bao³

Affiliations

¹ Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA. shk9078@med.cornell.edu.
² Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA. shk9078@med.cornell.edu.
³ Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Antiviral Agents / therapeutic use*
Health Services Accessibility*
Hepatitis C / drug therapy*
Humans
Insurance Coverage
Medicine
Practice Patterns, Physicians'*
United States

Substances

Antiviral Agents

Grants and funding